PentaTr@ining 2022: online course kicks off!

25 Apr, 2022

Our interactive course PentaTr@ining 2022: ‘HIV & other Congenital Infections’ kicks off today! The innovative online programme comprises 6 interactive and in-depth training modules, a wide variety of real-life clinical cases for…
Read More

Borrowing information across patient subgroups in clinical trials

23 Mar, 2022

An article by investigators within the ODYSSEY trial has been published as Open Access into BMC Medical Research Methodology. The investigators aimed to evaluate a treatment effect in a pre-defined subgroup…
Read More

Dolutegravir dosing for children with HIV weighing less than 20 kg

23 Mar, 2022

The results of an ODYSSEY pharmacokinetic sub-study investigating dolutegravir (DTG) based antiretroviral (ARV) treatments for children weighing 3 to less than 20kg have recently been published in The Lancet HIV as an…
Read More

What is PentaTr@ining

15 Mar, 2022

PentaTr@ining (formerly ‘Tr@inforPedHIV’) is a groundbreaking training platform for healthcare professionals caring for children, adolescents and pregnant women living with infectious diseases – with a particular focus on HIV and…
Read More

WHO Paediatric ARV dosing dashboard

14 Mar, 2022

The WHO have developed a Paediatric ARV dosing dashboard which aims to support health care workers, researchers and policy makers in decisions around ARV dosing for children. It includes a…
Read More

Penta stands with the Ukrainian people and those in Russia who are opposing war

02 Mar, 2022

On 24 February 2022, the Russian government deployed its military into its neighboring country, Ukraine. In these dark hours, we are tormented by the thought of our Ukrainian friends, the…
Read More

Gap-f launches strategy plan!

01 Mar, 2022

On March 1, 2022, the GAP-f network held a virtual event to launch its ambitious three-year strategy, spanning from 2022-2024. Through this event, the network solidified the WHO’s commitment to…
Read More

VERDI General Assembly Meeting

16 Feb, 2022

On 26-28 January the VERDI General Assembly Meeting took place – an exciting 3-day online event bringing together experts in infectious diseases from the EU and beyond. The aim was…
Read More

Ecraid begins its fight against infectious diseases 

15 Feb, 2022

New foundation: The European Clinical Research Alliance for Infectious Diseases has begun Utrecht, Tuesday 15 February 2022 – In January 2022, Ecraid became a legal entity and is now fully…
Read More

Closer to micro-elimination of HCV in Russian adolescents and children

11 Feb, 2022

The REACH Consortium has just published the results of a multi-centre survey, aimed at assessing the uptake of Direct-acting antivirals (DAAs) for the treatment of HCV in children and adolescents…
Read More

Registration now open! PentaTr@ining 2022: HIV & other Congenital Infections

11 Feb, 2022

We are delighted to announce that registrations are now open for our interactive training course ‘PentaTr@ining 2022: HIV & other Congenital Infections‘. Building on the remarkable success of the previous…
Read More

Save the date! Penta aperitivo webinar 17 Feb 2022

10 Feb, 2022

The Penta Aperitivo webinars are here to keep you up to date with the latest Penta activities and on the new developments on the prevention, diagnosis, and treatment of infectious diseases in children. The next…
Read More

PediCAP microbiology sub-study sites receive training from LAB-NET

08 Feb, 2022

At the end of 2021, LAB-Net provided training on the sampling and microbiology procedures to all five sites taking part in the microbiology sub-study in the Paediatric Community Acquired Pneumonia…
Read More

Science4Pandemics: A European Gamification Project to Better Prepare Young People for Future Pandemics

27 Jan, 2022

The digital platform will educate young people and provide real-world data for collaborative research on pandemics.   Barcelona, 27 January 2022. Despite the many advances in the global fight against…
Read More

COVID-19 vaccines for children, adolescents and immunocompromised patients

25 Jan, 2022

Penta is proud to be a partner in the Horizon Europe funded “RBD Dimer recombinant protein vaccine against SARSCoV2” (RBDCOV) project. Within the project we will be bringing our paediatric…
Read More

Once-daily DTG more effective in treating HIV in children

30 Dec, 2021

The ODYSSEY trial’s final paper Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children has been published in the New England Journal of Medicine. ODYSSEY, sponsored by Penta…
Read More

Ethical youth engagement in the HIV response

15 Dec, 2021

Penta youth in collaboration with IAS, have organised a webinar taking place on Thursday, 16 December at 12pm CET (GMT+1) on the theme Invest in our future: How to walk…
Read More

REACH project published in CORDIS

07 Dec, 2021

We are proud to announce that the REACH project’s Result in Brief article, Reducing infectious disease in mothers and children in Russia, has been uploaded on the CORDIS website. This…
Read More
1 2 3 4 5 22